Sufia Ahmad Khan et al. 2023. Study the technical validity and feasibility of serum HER-2/Neu and its correlation with tissue HER-2 status in female breast cancer patients only. Asian Journal of Medical Sciences. 14, 11 (Nov. 2023), 228–233.